文献速递腹部CT

肝脂肪变:中国与美国成人基于CT的患病率及与年龄、性别和体重指数的关联

Hepatic Steatosis: CT-Based Prevalence in Adults in China and the United States and Associations With Age, Sex, and Body Mass Index.
PubMed 文献 · AJR Am J Roentgenol · 2021-11-24

回顾性比较中国七省3176名成人与美国单一医疗中心8748名成人的未增强腹部CT校准脂肪分数,中国队列女性脂肪变患病率46.3%、男性58.9%,美国队列女性48.7%、男性61.9%;重度脂肪变美国队列高于中国队列,BMI不能可靠预测脂肪变。

要点

  • 中国队列女性脂肪变患病率46.3%、男性58.9%,美国队列女性48.7%、男性61.9%。
  • 重度脂肪变患病率中国女性0.9%、男性0.2%,美国女性1.8%、男性2.6%。
  • BMI正常者中中国队列36.8%、美国队列38.5%存在轻度脂肪变。

核心结论

  • 美国队列女性和男性的脂肪变及重度脂肪变患病率均高于中国队列。
  • BMI不能可靠预测脂肪变。
  • 调整后CT脂肪分数与BMI呈弱相关(r=0.312-0.431)。

研究设计与样本

  • 回顾性研究,纳入中国七省3176名成人(1985名女性、1191名男性)和来自美国单一医疗中心的8748名成人(4834名女性、3914名男性),均来自既往研究。
  • 所有参与者年龄至少40岁,既往研究中接受过未增强腹部CT。
  • CT肝脂肪含量测量通过体模与MRI质子密度脂肪分数测量交叉校准,以调整后FFCT表示。

关键影像表现/征象

  • 中国队列女性调整后FFCT中位数4.7%、男性5.8%;美国队列女性4.8%、男性6.2%。
  • 中国队列调整后FFCT在女性或男性中不随年龄十年段变化,而美国队列女性和男性中随年龄十年段增加。

诊断标准与关键数值

  • 轻度、中度和重度脂肪变分别定义为调整后FFCT 5.0-14.9%、15.0-24.9%和25.0%及以上。

临床应用与阅片要点

  • 基于未增强腹部CT校准的脂肪分数可用于人群层面对肝脂肪变患病率及其与年龄、性别、BMI关联的评估。
  • BMI正常者中中国队列36.8%、美国队列38.5%存在轻度脂肪变,中国队列3.0%、美国队列1.5%存在中度或重度脂肪变。
  • 美国队列BMI 40.0及以上者中17.7%肝脏脂肪含量正常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Calibrated CT fat fraction (FFCT) measurements derived from un-enhanced abdominal CT reliably reflect liver fat content, allowing large-scale population-level investigations of steatosis prevalence and associations. OBJECTIVE. The purpose of this study was to compare the prevalence of hepatic steatosis, as assessed by calibrated CT measurements, between population-based Chinese and U.S. cohorts, and to investigate in these populations the relationship of steatosis with age, sex, and body mass index (BMI). METHODS. This retrospective study included 3176 adults (1985 women and 1191 men) from seven Chinese provinces and 8748 adults (4834 women and 3914 men) from a single U.S. medical center, all drawn from previous studies. All participants were at least 40 years old and had undergone unenhanced abdominal CT in previous studies. Liver fat content measurements on CT were cross-calibrated to MRI proton density fat fraction measurements using phantoms and expressed as adjusted FFCT measurements. Mild, moderate, and severe steatosis were defined as adjusted FFCT of 5.0-14.9%, 15.0-24.9%, and 25.0% or more, respectively. The two cohorts were compared. RESULTS. In the Chinese and U.S. cohorts, the median adjusted FFCT for women was 4.7% and 4.8%, respectively, and that for men was 5.8% and 6.2%, respectively. In the Chinese and U.S. cohorts, steatosis prevalence for women was 46.3% and 48.7%, respectively, whereas that for men was 58.9% and 61.9%, respectively. Severe steatosis prevalence was 0.9% and 1.8% for women and 0.2% and 2.6% for men in the Chinese and U.S. cohorts, respectively. Adjusted FFCT did not vary across age decades among women or men in the Chinese cohort, although it increased across age decades among women and men in the U.S. cohort. Adjusted FFCT and BMI exhibited weak correlation (r = 0.312-0.431). Among participants with normal BMI, 36.8% and 38.5% of those in the Chinese and U.S. cohorts, respectively, had mild steatosis, and 3.0% and 1.5% of those in the Chinese and U.S. cohorts, respectively, had moderate or severe steatosis. Among U.S. participants with a BMI of 40.0 or greater, 17.7% had normal liver content. CONCLUSION. Steatosis and severe steatosis had higher prevalence in the U.S. cohort than in the Chinese cohort in both women and men. BMI did not reliably predict steatosis. CLINICAL IMPACT. The findings provide new information on the dependence of hepatic steatosis on age, sex, and BMI.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Guo, Blake, Graffy, et al. Hepatic Steatosis: CT-Based Prevalence in Adults in China and the United States and Associations With Age, Sex, and Body Mass Index. AJR Am J Roentgenol. 2021. PMID: 34817193. doi:10.2214/AJR.21.26728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。